FOXP3 and cancer: We also found higher FOXP3/TCRB ratio in tumor portions was significantly correlated with higher mutation load, which indicates a kind of immune balance between the cytolytic T cells and regulatory T cells in these tumors where immune checkpoint blockades may effectively work by activating pre-existing anti-cancer immunity.